Search clinical trials for: COBI placebo

Total 53701 results

Sorrento Therapeutics, Inc.

Withdrawn

Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress

Covid19 | ARDS

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise (BR)

Covid19
Fundacion SEIMC-GESIDA

Completed

A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study (DREAM)

HIV Infections

Spain
University of California, Los Angeles

Completed

An Inflammatory Challenge Using Endotoxin

Inflammatory Response | Alcohol Use Disorder | Craving | Depressed Mood

United States
Janssen Research & Development, LLC

Completed

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

HIV-1

United States
Codagenix, Inc

Completed

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

COVID-19

United Kingdom
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Healthy Volunteers

Germany
Keimyung University Dongsan Medical Center

Completed

The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study

Constipation

Korea, Republic of
Gamaleya Research Institute of Epidemiology and...
CREMS (Centre de Recherche Epidémiologie, Microbiologie et Soins médicaux )

Completed

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Ebola Virus Disease | Prevention

Russian Federation, Guinea
Sorrento Therapeutics, Inc.

Recruiting

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

Covid19

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome | Ards
Sorrento Therapeutics, Inc.

Terminated

Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress

Covid19

Brazil
Ardeypharm GmbH
ICON plc; Clinscience Sp. z o.o.

Completed

E. Coli Nissle 1917 - Suspension for Infection Prophylaxis (RONi)

Infections

Germany, Poland
Scandinavian Biopharma AB
Göteborg University; University of Virginia; University of Helsinki; Oy Medfiles... and other collaborators

Completed

Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC)

Diarrhea

Finland
Gamaleya Research Institute of Epidemiology and...
Acellena Contract Drug Research and Development

Recruiting

Study of Safety and Immunogenicity of BVRS-GamVac-Combi

MERS (Middle East Respiratory Syndrome) | MERS

Russian Federation
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19

Covid19

United States
ResMed

Completed

Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)

Chronic Obstructive Pulmonary Disease

United States
Nyamdavaa Tuul

Not yet recruiting

Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care

Metastatic Colorectal Cancer | Colorectal Cancer Stage IV
Total Child Health, Inc.
Boston Children's Hospital

Active, not recruiting

Online System for Primary Care to Prevent and Address Teen Substance Use (Substance)

Substance Use

United States
Sorrento Therapeutics, Inc.

Terminated

Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)

Covid19

United Kingdom
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19

Covid19
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19

Covid19
Radboud University Medical Center
UMC Utrecht

Completed

The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells (LPS-BM)

Sepsis, Endotoxemia, Immunosuppression

Netherlands
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

Covid19

United States
Sorrento Therapeutics, Inc.

Completed

Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)

Covid19

United States
Sorrento Therapeutics, Inc.

Withdrawn

Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection (US)

COVID-19
Novartis Pharmaceuticals

Completed

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years (EARLY)

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

Egypt, Greece, Hungary, Russian Federation, Canada, Germany, France, Italy, Switzerland, Romania
Intercell USA, Inc.

Completed

ETEC Logistics Trial (TREK) (Trek)

Diarrhea

United States, Guatemala, Mexico
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19

Covid-19
Intercell USA, Inc.

Completed

Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch

Diarrhea

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise

Covid19
Vrije Universiteit Brussel

Not yet recruiting

Cognitive Model for Behavioral Interventions as a Personalized Intervention for Patients With Serious Mental Illness

Psychiatric Disorder
Smith & Nephew, Inc.

Recruiting

Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures (CORI RCT UKA)

Avascular Necrosis | Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis | Requires Correction of Functional Deformity | Requires Treatment of Fractures That Were Unmanageable Using Other Techniques

New Zealand, Australia, Hong Kong
Smith & Nephew, Inc.

Recruiting

Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Knee Arthroplasty Procedures

Arthroplasty | Knee | Replacement

United States, United Kingdom, Germany, India
University Children's Hospital, Zurich

Completed

Comparing Forearm and Upper Arm Combi Cast for Distal Forearm Fractures in Children

Radius Fractures | Forearm Fracture | Salter-Harris Type I | Salter-Harris Type 2

Switzerland
University of Hohenheim
Ardeypharm GmbH

Completed

E. Coli Nissle in Oncology (EcNO)

Gastric Cancer | Colorectal Cancer

Germany
St. Justine's Hospital
Shriners Hospitals for Children

Recruiting

Development and Validation of the MOBI Questionnaire (MOBI)

Idiopathic Scoliosis

Canada
OBI Pharma, Inc

Completed

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

Metastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric Cancer

Taiwan
NIZO Food Research
FrieslandCampina

Completed

The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection (MIRRE)

Diarrhea

Netherlands
University of California, Davis

Completed

Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings (BHCOEMobi)

Psychosis | Clinical High Risk for Psychosis

United States
Region Skane
Coloplast A/S; Lund University Hospital; Swedish Institute for Infectious Disease... and other collaborators

Completed

E. Coli 83972 Induced Asymptomatic Bacteriuria (ABU) in Patients With Recurrent Urinary Tract Infections (UTI)

Urinary Tract Infection

Sweden
Nino Fijačko

Recruiting

Impact of Mobile Phone Application Use on Adult BLS (MOBI-CPR)

Stress | Knowledge, Attitudes, Practice | Mobile Phone Use | Out-Of-Hospital Cardiac Arrest

Slovenia
Fatih Sultan Mehmet Training and Research Hospital

Active, not recruiting

THE EFFECT OF FAST WEIGHT EFFICIENCY AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY ON THE COBB ANGLE IN MORBID OBESE PATIENTS

Back Pain | Scoliosis | Obesity, Morbid

Turkey
University of Miami
Ludwig Medical Corporation

Terminated

Efficacy of Suction Enabled Retraction Device

Surgical Blood Loss | Spinal Surgery

United States
Rigshospitalet, Denmark

Unknown

Study of Renal Blood Flow During Human Endotoxemia

Healthy | Type 2 Diabetes | Endotoxemia

Denmark
Herlev Hospital

Unknown

Low-Dose Endotoxemia and the Acute Phase Response

Sepsis | Endotoxemia

Denmark
International Vaccine Institute
Indian Council of Medical Research; Institute of Child Health; National Institute... and other collaborators

Unknown

Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants

Diarrhea | Cholera | Vibrio Infections

India
Johns Hopkins Bloomberg School of Public Health
PATH Vaccine Solutions

Completed

Low-dose Challenge Model With Enterotoxigenic E Coli

Diarrhea

United States
Alice Andreassi
Lo.Li.Pharma s.r.l; Azienda Ospedaliera San Paolo

Unknown

Evaluating the Effect of Inositol Supplementation in Overweight Children on Basal Insulin and Body Weight

Insulin Resistance

Italy
Gilead Sciences

Completed

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

HIV Infections | Acquired Immunodeficiency Syndrome

United States, Puerto Rico

Search clinical trials for: COBI placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations